Fig. 3
Impact of atovaquone 32% (ATV-32%) across transmission cycles and mosquito biting rates. The transmission-blocking (prevalence) (a and c) and transmission-reducing (intensity) (b and d) efficacy (%) and critical binomial 95% credible intervals (shaded regions around lines) generated from the model simulated treatment and control posterior distributions of the parasite density per individual for each biting rate (the number of mosquitoes that fed on each mouse, row 1) or transmission cycle (row 2)